Related Experiment Video
Updated: Jun 2, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Presentations of primary hypersomnia in Chinese children
1Department of Pulmonary Medicine, Beijing University People’s Hospital, Beijing, China. hanfang1@hotmail.com
Insights
Childhood narcolepsy with cataplexy is common in China, often starting before age 10. Sleep paralysis increased with age, but diagnostic criteria remained consistent across puberty.
Area of Science:
- Neurology
- Sleep Medicine
- Pediatrics
Background:
- Primary hypersomnia in children presents diagnostic challenges.
- Narcolepsy-cataplexy is a significant subset of childhood hypersomnia.
- Understanding early-onset narcolepsy is crucial for timely diagnosis and management.
Purpose of the Study:
- To describe the clinical characteristics of childhood primary hypersomnia in a Chinese population.
- To emphasize the prevalence and presentation of narcolepsy-cataplexy in pediatric patients.
- To investigate the impact of puberty on the presentation of narcolepsy-cataplexy.
Main Methods:
- Retrospective analysis of 417 children (<18 years) with hypersomnia.
- Utilized Stanford Sleep Inventory, HLA DQB1*0602 typing, and Multiple Sleep Latency Test (MSLT).
- Measured CSF hypocretin-1 in a subset to confirm hypocretin deficiency.
Main Results:
- 86% of children met criteria for narcolepsy with or without cataplexy.
- Narcolepsy onset occurred significantly earlier in males, with 70% starting before age 10.
- Sleep paralysis frequency increased with age, while MSLT results remained consistent across puberty.
Conclusions:
- Narcolepsy with cataplexy is highly prevalent in Chinese children presenting with primary hypersomnia.
- Early-onset narcolepsy in this cohort begins at a younger age than previously reported.
- Sleep paralysis is a key symptom that evolves with age in pediatric narcolepsy.
Objective:
To retrospectively describe childhood presentations of primary hypersomnia with an emphasis on narcolepsy-cataplexy in a Chinese population.
Methods:
A total of 417 children (< 18 years old) successively presenting with complaints of hypersomnia without anatomic cause or sleep apnea risk were evaluated using the Stanford Sleep Inventory, human leukocyte antigen (HLA) DQB1*0602 typing, and MSLT recordings. CSF hypocretin-1 was measured in 47 cases to document hypocretin deficiency. A subgroup ("narcolepsy/hypocretin deficiency") with likely hypocretin deficiency (low hypocretin-1 or HLA positive with clear-cut cataplexy) was further examined for presentations prior to, around, or after puberty.
Results:
Narcolepsy with (n = 361) or without (n = 17) cataplexy presented at an earlier age and with increased male predominance when compared to idiopathic hypersomnia (n = 39, P < 0.01). Nearly 70% of those with narcolepsy/hypocretin deficiency (n = 271) had disease onset before age 10 y, and 15% had onset before age 6, an unusually young age distribution. Onset was prior to puberty in 78% of cases. Clinical features were similar in presentations across puberty groups except for sleep paralysis, which increased in frequency with age/puberty. Mean sleep latency (MSL) decreased and the number of sleep onset REM periods (SOREMPs) increased with age/puberty, but MSLT diagnosis criteria (MSL ≤ 8 min, ≥ 2 SOREMPs) were similarly positive across groups. Familial clustering was present in only 1.7% of probands.
Conclusion:
In children presenting with a complaint of primary hypersomnia to a sleep clinic in China, 86% (361/417) meet criteria for narcolepsy with cataplexy. Puberty did not affect positivity on the MSLT as a diagnostic feature. Sleep paralysis was the only symptom that increased with increasing age. In addition, narcolepsy with cataplexy in our clinic population appeared to begin at a younger age than usually reported in other studies.
More Related Videos
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
Related Concept Videos
Narcolepsy
Management of Insomnia
Insomnia
Multiple factors contribute...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...